Press & News Global Genomics Group (G3) Granted Patent for Breakthrough Diagnostic Blood Test for Plaque Detection in the Heart News Global Genomics Group (G3) Presents Data for the First Time on the Exact Size of Lipoprotein (a) Particles that Cause Plaque Buildup in Coronary Arteries from its GLOBAL Clinical Study Platform News Global Genomics Group and Datavant Announce Strategic Partnership to Improve Design and Interpretation of Clinical Trials News Global Genomics Group (G3) and GNS Healthcare Report Preliminary Results of Largest-Ever Study Linking Biomarkers with Coronary Artery Disease News Global Genomics Group (G3) Partners with Sanofi to Identify New Signaling Pathways in Atherosclerotic Cardiovascular Diseases News GLOBAL Design Manuscript Published in Journal of Cardiovascular Computed Tomography News Omixon Collaborates with G3 and Genomics England to Validate HLA Genotyping from WGS Data News Global Genomics Group (G3) Announces Completion of Enrollment in GLOBAL Study with 7,500 Patients News GLOBAL GENOMICS GROUP (“G3″) APPOINTS HARRY “CHIP” DAVIS, ZETIA® INVENTOR, AS CHIEF DRUG DEVELOPMENT OFFICER News GLOBAL GENOMICS GROUP (G3) AND CAPRION TO PARTNER ON GLOBAL STUDY TO IDENTIFY CARDIOVASCULAR DISEASE BIOMARKERS AND DRUG TARGETS News G3, QUINTILES ENTER TARGET DISCOVERY ALLIANCE News GLOBAL GENOMICS GROUP (G3) COMPLETES PATIENT ENROLLMENT OF DISCOVERY COHORT IN GLOBAL STUDY AHEAD OF SCHEDULE News Articles -OMICS OVERDRIVE Articles IDENTIFICATION OF NOVEL CARDIOVASCULAR DISEASE PATHWAYS, BIOMARKERS Articles THE 3 PILLARS TO UNDERSTANDING CARDIOVASCULAR DISEASE Articles INTERVIEW WITH DR. SZILARD VOROS, CEO AND CO-FOUNDER OF GLOBAL GENOMICS GROUP Articles
